Ankylosing spondylitis in sub-Saharan Africa

Postgraduate Medical Journal

Volumn 85, Issue 1005, 2009, Pages 353-357

  Belachew, D A ^a   Sandu, N ^a   Schaller, B ^a   Guta, Z ^a  

^a ADDIS ABABA UNIVERSITY   (Ethiopia)

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; C REACTIVE PROTEIN; DICLOFENAC; ETANERCEPT; HLA B27 ANTIGEN; HLA DR ANTIGEN; IMMUNOSUPPRESSIVE AGENT; INDOMETACIN; INFLIXIMAB; INTERLEUKIN 1 RECEPTOR; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; SALAZOSULFAPYRIDINE; STEROID; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

AFRICA; AGE DISTRIBUTION; ANEMIA; ANKYLOSING SPONDYLITIS; ANKYLOSIS; AORTA VALVE REGURGITATION; ARTHRITIS; BACKACHE; BONE EROSION; BREATHING EXERCISE; CHRONIC INFLAMMATION; CHRONIC PAIN; CONVALESCENCE; ERYTHROCYTE SEDIMENTATION RATE; FAMILY HISTORY; FLEXION CONTRACTURE; GAMBIA; GENETIC MARKER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; IRIDOCYCLITIS; IRITIS; JOINT INJURY; KINESIOTHERAPY; KYPHOSIS; LIFE EXPECTANCY; LIFESTYLE MODIFICATION; LUNG DISEASE; MULTIPLE CYCLE TREATMENT; NORTH AMERICA; ONSET AGE; ORTHOPEDIC SURGERY; PALLIATIVE THERAPY; PHYSIOTHERAPY; PREVALENCE; RARE DISEASE; REVIEW; RIGIDITY; SENEGAL; SEX RATIO; SLEEP; SMOKING CESSATION; SPINE FRACTURE; SPINE FUSION; SPINE MALFORMATION; SPONDYLOARTHROPATHY; STEROID THERAPY; SYSTEMIC DISEASE; TREATMENT RESPONSE; WALKING; WESTERN EUROPE;

ADULT; AFRICA SOUTH OF THE SAHARA; CHRONIC DISEASE; HLA-B27 ANTIGEN; HUMANS; SPONDYLITIS, ANKYLOSING; YOUNG ADULT;

EID: 67650469086     PISSN: 00325473     EISSN: 14690756     Source Type: Journal    
DOI: 10.1136/pgmj.2007.064717     Document Type: Review

References (40)

1. Braun J, Sieper J. Ankylosing spondylitis. Lancet 2007;369:1379-1390
2. Sengupta R, Stone MA. The assessment of ankylosing spondylitis in clinical practice. Nat Clin Pract Rheumatol 2007;3:496-503. (Pubitemid 47351394)
3. Brophy S, Mackay K, Al-Saidi A, et al. The natural history of ankylosing spondylitis as defined by radiological progression. J Rheumatol 2002;29:1236-1243 (Pubitemid 34601961)
4. Freedman BA, Potter BK, Kuklo TR. Managing neurologic complications in cervical spine surgery, Curr Opin Orthoped 2005;16:169-177 (Pubitemid 40780501)
5. Vercelli L, Mongini T, Mutani R, et al. Complement-mediated muscle involvement in juvenile ankylosing spondylitis. Basic Appl Myol 2004;14:79-81
6. Wordsworth BP, Mowat AG. A review of 100 patients with ankylosing spondylitis with particular reference to socio-economic effects. Br J Rheumatol 1986;25:175-180 (Pubitemid 16033799)
7. Vosse D, Feldtkeller E, Erlendsson J, et al. Clinical vertebral fractures in patients with ankylosing spondylitis. J Rheumatol 2004;31:1981-1985 (Pubitemid 39336723)
8. Young A. Cauda equina syndrome complicating ankylosing spondylitis: use of electromyography and computerised tomography in diagnosis. Ann Rheum Dis 1981;40:317-322 (Pubitemid 11122552)
9. Bartleson JD, Cohen MD, Harrington TM, et al. Cauda equina syndrome secondary to long-standing ankylosing spondylitis. Ann Neurol 1983;14:662-669 (Pubitemid 14211613)
10. Tyrrell PN, Davies AM, Evans N. Neurological disturbances in ankylosing spondylitis. Ann Rheum Dis 1994;53:714-717
11. Moustafa M, Owonayo O, Khan MA. Spondyloarthropathies in sub-Saharan Africa. Curr Opin Rheumatol 2000;12:281-286
12. Inman RD. Mechanisms of disease: infection and spondyloarthritis. Nat Clin Pract Rheumatol 2006;2:163-169
13. Brown MA. Non-major-histocompatibility-complex of ankylosing spondylitis. Best Pract Res Clin Rheumatol 2006;20:611-621
14. Gonzalez-Lopez L, Garcia-Gonzalez A, Vazquez-Del-Mercado M, et al. Efficacy of methotrexate in ankylosing spondylitis: a randomized, double blind, placebo controlled trial. J Rheumatol 2004;31:1568-1574 (Pubitemid 39006639)
15. Mijiyawa M. Spondyloarthropathies in patients attending the rheumatology unit of Lomé hospital. J Rheumatol 1993;20:1167-1169 (Pubitemid 23278169)
16. Chalmers IM. Ankylosing spondylitis in African blacks. Arthritis Rheum 1980;23:1366-1370
17. Brown MA, Jepson A, Young A, et al. Ankylosing spondylitis in West Africans: evidence for non-HLA B27 protective effect. Ann Rheum Dis 1997;56:68-70. (Pubitemid 27060577)
18. Stein M, Davies P. Rheumatic disorders in Zimbabwe: a prospective analysis of patients attending the rheumatic diseases clinic. Ann Rheum Dis 1990;49:400-402 (Pubitemid 20170520)
19. Khan MA, Braun WE, Kushner I, et al. HLA-B27 in ankylosing spondylitis: differences in frequency and relative risk in American Blacks and Caucasians. J Rheumatol 1977;4(suppl 3):39-43.
20. Khan MA, Kushner I, Braun WE. Comparison of clinical features of HLA-B27 positive and negative patients with ankylosing spondylitis. Arthritis Rheum 1977;20:909-912
21. Lopez-Larrea C, Mijiyawa M, Gonzalez S, et al. Association of ankylosing spondylitis with HLA-B*1403 in a West African population. Arthritis Rheum 2002;46:2968-2971 (Pubitemid 35315890)
22. Khan MA. HLA-B27 and its subtypes in world populations. Curr Opin Rheumatol 1995;7:263-269
23. Braun J, Bollow M, Remlinger G, et al. Prevalence of spondylarthropathies in HLAB27 positive and negative blood donors. Arthritis Rheum 1998;41:58-67. (Pubitemid 28041923)
24. Rudwaleit M, Khan MA, Sieper J. The challenge of diagnosis and classification in early ankylosing spondylitis: do we need new criteria? Arthritis Rheum 2005;52:1000-1008
25. Sporenberg A, van der Heijde D, de Klerk E, et al. Relative value of erythrocyte sedimentation rate and C-reactive protein in assessment of disease activity in ankylosing spondylitis. J Rheumatol 1999;26:980-984 (Pubitemid 29195698)
26. Kellgren JH, Jeffrey MR, Ball J. The epidemiology of chronic rheumatism, vol 1 Oxford: Blackwell, 1963.
27. van der Linden SM, Valkenburg HA, De Jongh BM, et al. The risk of developing ankylosing spondylitis in HLA-B27 positive individuals. Arthritis Rheum 1984;27:241-249
28. Dagfinrud H, Kvien TK, Hagen KB. The Cochrane review of physiotherapy interventions for ankylosing spondylitis. J Rheumatol 2005;32:1899-1906 (Pubitemid 41429019)
29. Hidding A, van der Linden S. Factors related to change in global health after group physical therapy in ankylosing spondylitis. Clin Rheumatol 1995;14:347-351
30. Bollow M, Brain J, Hamm B. Early sacroilitis in patients with spondylarthropathy: evaluation with dynamic gadolinium-enhanced. Radiology 1995;194:529-536
31. Rudwaleit M, van der Heijde D, Khan MA, et al. How to diagnose axial spondyloarthritis early. Ann Rheum Dis 2004;63:535-543 (Pubitemid 38530197)
32. Manadan AM, James N, Block JA. New therapeutic approaches for spondyloarthritis. Curr Opin Rheumatol 2007;19:259-264
33. Chen J, Liu C. Is sulfasalazine effective in ankylosing spondylitis? A systematic review of randomized controlled trials. J Rheumatol 2006;33:722-731
34. Clegg DO, Reda DJ, Abdellatif M. Comparison of sulfasalazine and placebo for the treatment of axial and peripheral articular manifestations of the seronegative spondylarthropathies: a Department of Veterans Affairs cooperative study. Arthritis Rheum 1999;42:2325-2329 (Pubitemid 30333412)
35. Dougados M, vam der Linden S, Leirisalo-Repo M, et al. Sulfasalazine in the treatment of spondylarthropathy. A randomized, multicenter, double-blind, placebocontrolled study. Arthritis Rheum 1995;38:618-627
36. Sampaio-Barros PD, Costallat LT, Bertolo MB, et al. Methotrexate in the treatment of ankylosing spondylitis. Scand J Rheumatol 2000;29:160-162
37. Baraliakos X, Brandt J, Listing J, et al. Outcome of patients with active ankylosing spondylitis after two years of therapy with etanercept: clinical and magnetic resonance imaging data. Arthritis Rheum 2005;53:856-863 (Pubitemid 41811126)
38. Maksymowych WP, Jhangri GS, Fitzgerald AA, et al. A six-month randomized, controlled, double-blind, dose response comparison of intravenous pamidronate (60 mg versus 10 mg) in the treatment of nonsteroidal antiinflammatory drugrefractory ankylosing spondylitis. Arthritis Rheum 2002;46:766-773 (Pubitemid 34214258)
39. Maksymowych WP, Lambert R, Jhangri GS, et al. Clinical and radiological amelioration of refractory peripheral spondyloarthritis by pulse intravenous pamidronate therapy. J Rheumatol 2001;28:144-155 (Pubitemid 32062038)
40. Belachew D, Schaller B, Guta Z. Cervical spondylosis: a literature review with attention to the African population. Arch Med Sci 2007;3:315-322 (Pubitemid 351212279)